市场调查报告书
商品编码
1333976
转移膜市场:现状分析与预测(2022-2030)Transfer Membrane Market: Current Analysis and Forecast (2022-2030) |
预计 2022 年至 2030 年,转移膜市场的复合年增长率约为 5%。 转移膜市场是指涉及转移膜生产、分销和销售的全球行业。 转移膜也称为印迹膜,是用于各种生物和分析技术(包括蛋白质印迹、南方印迹和北方印迹)的专用多孔材料。 转移膜旨在促进蛋白质、DNA 和 RNA 等生物分子从凝胶基质转移到固体支持物(通常是膜表面)。 常用于分子生物学研究、生物技术和临床诊断。 由于传染病和遗传性疾病在世界各地变得越来越普遍,对转移膜的需求不断增加。 例如,根据 HIV.gov 的数据,预计到 2021 年,全球将有 150 万人感染艾滋病毒,同年将有约 3840 万人感染艾滋病毒。 有瞭如此引人注目的统计数据,全球遗传疾病的发病率正在上升,这也将有助于未来的市场增长。 此外,由于学术机构、研究机构和工业实验室的研发活动投资不断增加,转移膜市场预计将增长。 此外,人们越来越关注蛋白质和基因的结构和功能,这增加了对蛋白质印迹、南方印迹和北方印蹟等技术的转移膜的需求。 然而,转移膜成本高、膜堵塞和可重复使用性有限等一些市场限制因素阻碍了该市场在全球范围内的增长。
按产品划分,市场分为 PVDF、硝化纤维和尼龙。 其中,PVDF细分市场在2021年占据较大市场份额。 PVDF 转移膜为其他膜类型提供了极其耐用且具有化学惰性的替代品,同时促进蛋白质剥离和重新探测。 由于这些膜是疏水性的,它们可以与蛋白质形成牢固的接触,从而实现更好的蛋白质结合和有效的蛋白质运输。
根据转印方式,市场分为湿式或槽式转印、半干式电印迹(半干式转印)、干式电印迹(干式转印)等。 其中,干式电印迹细分市场由于其用户友好且方便的操作方法以及早期转移速度等优势,预计将以较高的复合年增长率增长。 此外,该技术不需要用缓衝液进行凝胶平衡,从而减少了完成转移所需的时间。
根据应用,市场分为蛋白质印迹、南方印迹、北方印蹟等。 其中,Western blotting领域预计市场将以较高的复合年增长率增长。 这是因为该技术广泛应用于诊断和临床测试。 Western blotting对于蛋白质检测具有高灵敏度和特异性的优点,可作为一种分析工具。
按最终用户分为生物製药/製药公司、学术/研究机构、诊断实验室。 其中,生物製药和製药公司类别已获得显着的市场份额,预计在预测期内将以显着的复合年增长率增长。 此类投资可能会增加转移膜等分子生物学方法的使用,从而使市场受益。
为了更好地了解转移膜的市场介绍,市场有北美(美国、加拿大、北美其他地区)、欧洲(德国、法国、意大利、西班牙、英国、欧洲其他地区)、亚太地区(中国,根据在世界其他地区(日本、印度、其他亚太国家)和世界其他地区的全球影响力进行分析。 北美,尤其是美国,是生物技术和药物研究的中心。 该地区在蛋白质组学、基因组学、个性化医疗和药物发现等领域取得了重大进展。 这些进步增加了对转移膜作为各种研究和诊断应用的重要工具的需求。 此外,政府、私人组织和学术研究机构为北美的生命科学研究分配了大量资金。 此类资金支持利用转移膜的研究项目,包括蛋白质分析、核酸研究和生物标誌物发现。 成熟的研究基础设施的存在以及政府在生命科学领域不断增加的投资正在推动北美地区对转移膜的需求。 例如,2022 年 9 月,美国卫生与公众服务部宣布投资超过 4000 万美元,以扩大该国的生物技术研究和製造,作为国家生物技术和生物製造计划的一部分。
Thermo Fisher Scientific、Danaher、Bio-Rad Laboratories、Merck KGaA、PerkinElmer、Abcam、Santa Cruz Biotechnology、ATTO、Azure Biosystems、Advancesta 等大型公司。 还有一些併购和联盟。
The transfer membrane market is expected to register a CAGR of approx. 5% over the period of 2022-2030. The transfer membrane market refers to the global industry involved in the production, distribution, and sale of transfer membranes. Transfer membranes, also known as blotting membranes, are specialized porous materials used in various biological and analytical techniques, such as Western blotting, Southern blotting, and Northern blotting. Transfer membranes are designed to facilitate the transfer of biological molecules, such as proteins, DNA, and RNA, from a gel matrix onto a solid support, typically a membrane surface. They are commonly used in molecular biology research, biotechnology, and clinical diagnostics. The growing demand for transfer membranes can be attributed to the high prevalence of infectious and genetic diseases around the globe. For instance, according to HIV.gov, an estimated 1.5 million individuals worldwide acquired HIV infection in 2021, while around 38.4 million individuals were suffering from the disease in the same year. Owing to the glaring statistics growth of genetic disease across the globe would contribute to the growth of the market in the forthcoming period as well. Furthermore, the transfer membrane market is anticipated to grow on account of the increasing investment in research and development activities across academic institutions, research organizations, and industrial laboratories. Moreover, the increasing focus on understanding the structure and function of proteins and genes has led to a growing demand for transfer membranes in techniques such as western blotting, southern blotting, and northern blotting. However, some of the restraints in the market including the high cost of transfer membranes and membrane clogging and limited reusability are impeding the growth of this market all over the world.
Based on product, the market is segmented into PVDF, nitrocellulose, and nylon. Among them, the PVDF segment captured a significant share of the market in 2021. PVDF transfer membranes make easier protein stripping and re-probing possible while providing an extremely durable and chemically inert alternative to other kinds of membranes. Because these membranes are hydrophobic, they can form strong contacts with proteins, allowing for better protein binding and efficient protein transport.
Based on the transfer, the market is bifurcated into wet or tank transfer, semi-dry electroblotting (semi-dry transfer), dry electroblotting (dry transfer), and others. Among them, the dry electroblotting segment is expected to grow at a higher CAGR in the market owing to the benefits, such as its user-friendly and convenient manner of operation as well as early transfer speed. Furthermore, the approach eliminates the requirement to equilibrate gels in a buffer, lowering the time required to complete the transfer.
Based on the application, the market is bifurcated into western blotting, southern blotting, northern blotting, and others. Among them, the western blotting segment is expected to grow at a higher CAGR in the market. This can be ascribed to the technique's widespread use in diagnostic and clinical testing activities. Western blotting has advantages for protein detection such as high sensitivity and specificity, allowing it to be used as an analytical tool.
Based on the end-user, the transfer membrane market has been classified into biopharmaceutical & pharmaceutical companies, academic & research institutes, and diagnostic labs. Among them, the into biopharmaceutical & pharmaceutical companies category grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. the increased research and development operations conducted by such corporations for the discovery of innovative medicines and vaccines. Such investments are likely to increase the use of molecular biology techniques such as transfer membranes, which will benefit the market.
For a better understanding of the market adoption of transfer membrane, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. North America, particularly the United States, is a hub for biotechnology and pharmaceutical research. The region is witnessing significant advancements in areas such as proteomics, genomics, personalized medicine, and drug discovery. These advancements drive the demand for transfer membranes as essential tools in various research and diagnostic applications. Moreover, governments, private organizations, and academic institutions in North America allocate substantial funding for life sciences research. The availability of funding supports research projects that rely on transfer membranes for protein analysis, nucleic acid studies, and biomarker discovery. This financial support contributes to the growth of the transfer membrane market in the region. the presence of well-established research infrastructure and rising government investments in the life sciences domain drive the demand for transfer membranes in the North America region. For instance, in September 2022, the U.S. Department of Health and Human Services declared an investment of above USD 40.0 million as a part of the National Biotechnology and Bio-manufacturing initiative for the expansion of biotechnology research and manufacturing in the country.
Some of the major players operating in Thermo Fisher Scientific, Inc.; Danaher; Bio-Rad Laboratories; Merck KGaA; PerkinElmer, Inc.; Abcam Plc.; Santa Cruz Biotechnology, Inc.; ATTO Corporation; Azure Bio systems Inc.; Advansta Inc among others. Several M&A's along with partnerships have been undertaken.
13 TRANSFER MEMBRANE MARKET OPPORTUNITIES